Furthermore, among the 19 cases of colon adenocarcinoma (12 cases with identified metastases) examined, only 1 (5.3%) exhibited an alteration in the ERBB2 gene that was associated with the initiation of therapy. This evidence concerns the gene ERBB2 and colon adenocarcinoma.